Argent BioPharma Limited (RGTLF)

Argent BioPharma Revenue

In the fiscal year ending June 30, 2025, Argent BioPharma had annual revenue of 180.57K AUD, down -79.74%. Argent BioPharma had revenue of 176.28K in the half year ending June 30, 2025, a decrease of -75.68%.

• Revenue: 180.57K AUD
• Revenue Growth: -79.74%
• P/S Ratio: 29.69
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 3.52M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	180.57K	-710.52K	-79.74%
Jun 30, 2024	891.08K	-2.50M	-73.70%
Jun 30, 2023	3.39M	-1.34M	-28.41%
Jun 30, 2022	4.73M	1.74M	57.94%
Jun 30, 2021	3.00M	916.88K	44.10%